Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • More Than $875,000 Raised at the 2017 Answer to Cancer Cycling Event and 5K Family Fun Run and Walk

    With more than 450 bikers, runners, walkers, and volunteers, the 2017 Answer to Cancer was the best…

    July 15, 2017| Katherine McCluskey
  • Rational Combinations 360° Seeks Improved Immunotherapy Approaches for Patients

    Top immunotherapy experts from both academia and industry will convene for the 2nd annual Rational Combinations 360°…

    June 27, 2017| Arthur N. Brodsky, PhD
  • Ask a Scientist About Cancer Immunotherapy Clinical Trials

    Dr. Michael Postow responds to patient questions about clinical trials, including finding one, what the different stages…

    June 27, 2017| CRI Staff
  • CRI’s CEO, Scientific Advisors Headline Cancer Immunotherapy Forum

    The future of immunotherapy is in finding the right combinations

    June 23, 2017| Arthur N. Brodsky, PhD
  • ASCO17 Recap: 7 Takeaways from the World’s Premier Clinical Cancer Conference

    ASCO17’s presentations reveal that the field of immunotherapy is advancing along many fronts

    June 16, 2017| Arthur N. Brodsky, PhD
  • ASCO17: Days 4 and 5 Immunotherapy Highlights

    Days 4 and 5 at ASCO17 showed off the overall scope of immunotherapy’s efforts to provide clinical…

    June 6, 2017| Arthur N. Brodsky, PhD
  • ASCO17: Day 3 Immunotherapy Highlights

    Day 3 at the 2017 annual meeting of the American Society of Clinical Oncology touched on immunotherapy…

    June 5, 2017| Arthur N. Brodsky, PhD
  • ASCO17: Day 2 Immunotherapy Highlights

    Day 2 at the 2017 annual meeting of the American Society of Clinical Oncology further highlighted immunotherapy's…

    June 4, 2017| Arthur N. Brodsky, PhD
  • ASCO17: Day 1 Immunotherapy Highlights

    Day 1 at the 2017 annual meeting of the American Society of Clinical Oncology demonstrated immunotherapy’s potential…

    June 3, 2017| Arthur N. Brodsky, PhD
Previous Page
1 … 64 65 66 67 68 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal